Cover Image

Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives

Enrico Torre,1 Sergio Di Matteo,2 Giacomo Matteo Bruno,3 Chiara Martinotti,2 Maria Chiara Valentino,2 Gianni Testino,4 Alberto Rebora,1 Luigi Carlo Bottaro,5 Giorgio Lorenzo Colombo3 1Diabetology and Metabolic Diseases Unit - ASL3, Genoa, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche S.r.l.,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Torre E (Author), Di Matteo S (Author), Bruno GM (Author), Martinotti C (Author), Valentino MC (Author), Testino G (Author), Rebora A (Author), Bottaro LC (Author), Colombo GL (Author)
Format:	Book
Published:	Dove Medical Press, 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives
by: Torre E, et al.
Published: (2024)

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study
by: Torre E, et al.
Published: (2020)

Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy
by: Poli A, et al.
Published: (2015)

Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes
by: Torre E, et al.
Published: (2018)

Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus
by: Torre E, et al.
Published: (2021)

Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy
by: Colombo GL, et al.
Published: (2012)

Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
by: Colombo GL, et al.
Published: (2023)

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
by: Colombo GL, et al.
Published: (2018)

Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II
by: Enrico Torre, et al.
Published: (2020)

Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study
by: Canonica GW, et al.
Published: (2020)

The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis
by: Colombo GL, et al.
Published: (2018)

Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids
by: Mohamed Elbadawy, et al.
Published: (2023)

Non-Alcoholic Steatohepatitis (NASH) – A Review of a Crowded Clinical Landscape, Driven by a Complex Disease
by: Fraile JM, et al.
Published: (2021)

Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-alfa as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH)
by: Hery D Purnomo, et al.
Published: (2015)

Prediction of the mechanisms of action of Qutan Huoxue decoction in non-alcoholic steatohepatitis (NASH): a network pharmacology study and experimental validation
by: Xia Wu, et al.
Published: (2023)

FAT score: an Indian insight to a novel diagnostic score to differentiate non-alcoholic steatohepatitis (NASH) from simple steatosis
by: Jijo Varghese, et al.
Published: (2021)

Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
by: James Twiss, et al.
Published: (2023)

Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
by: Eleftheria Galatou, et al.
Published: (2022)

Burden of Crohn’s disease: economics and quality of life aspects in Italy
by: Benedini V, et al.
Published: (2012)

Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design
by: Xianwen Chen, et al.
Published: (2023)

Non-alcoholic Steatohepatitis (NASH) Drug Discovery - Building a Consensus on ADME Screening Tools and Clinical Pharmacology Strategies to Aid Candidate Development
by: Ranjeet Prasad Dash, et al.
Published: (2018)

Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
by: Yuezhi Zhu, et al.
Published: (2024)

Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non‐alcoholic steatohepatitis (NASH)
by: Natsuko Hada, et al.
Published: (2023)

Is non-alcoholic steatohepatitis caused by alcohol?
by: Hubert E Blum
Published: (2020)

Genistein Modulated Lipid Metabolism, Hepatic PPARγ, and Adiponectin Expression in Bilateral Ovariectomized Rats with Nonalcoholic Steatohepatitis (NASH)
by: Sudaporn Pummoung, et al.
Published: (2020)

Fructose and Non-Alcoholic Steatohepatitis
by: Elke Roeb, et al.
Published: (2021)

Economic burden of pneumococcal disease in children in Liguria, Italy
by: Daniela Amicizia, et al.
Published: (2022)

Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen
by: Colombo GL, et al.
Published: (2013)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010)

Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy
by: Ruggeri I, et al.
Published: (2012)

Tocopheryl quinone improves non-alcoholic steatohepatitis (NASH) associated dysmetabolism of glucose and lipids by upregulating the expression of glucagon-like peptide 1 (GLP-1) via restoring the balance of intestinal flora in rats
by: Tao Sun, et al.
Published: (2021)

Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis
by: Oksana Khukhlina, et al.
Published: (2021)

Induction of Steatohepatitis (NASH) with Insulin Resistance in Wild-type B6 Mice by a Western-type Diet Containing Soybean Oil and Cholesterol
by: Janin Henkel, et al.
Published: (2017)

Non-Alcoholic Steatohepatitis: Clinical and Translational Research
by: Manuela G Neuman, et al.
Published: (2016)

Ductular reaction in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: O. M. Gavrilyuk
Published: (2014)

A significant and persistent rise in the global burden of adolescent NAFLD and NASH estimated by BMI
by: Xiao-Yun Lin, et al.
Published: (2024)

Current, emerging, and potential therapies for non-alcoholic steatohepatitis
by: Zhen Yang, et al.
Published: (2023)

NAShI AVTORY
by: -
Published: (2016)

NAShI AVTORY
by: -
Published: (2015)

NAShI AVTORY
by: -
Published: (2016)